Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting

Figure 4

One-way sensitivity analysis. This tornado diagram illustrates the results of a one-way sensitivity analysis of key input parameters. The ranges of incremental cost-effectiveness ratios (ICERs) for the MSI-H: PEM/MSS: PAC strategy compared to the PAC for all patients’ strategy are plotted.